Acumen Pharmaceuticals Inc. (ABOS) Total Business Assets
Acumen Pharmaceuticals (ABOS) is creating a closed ecosystem to combat Alzheimer's disease using proprietary antibodies against amyloid oligomers. The price history on this chart confirms asset dynamics, which currently stand at 113.89. Business potential is fueled by data on the ACU193 drug and the global aging population. Technological superiority is ensured by patents for safe molecules, creating a significant barrier for competitors in the biotech sector.
Analytical breakdowns for Acumen Pharma (ABOS)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Acumen Pharmaceuticals|ABOS - Long-Term Debt to Equity|Current Liabilities to Capital Acumen Pharmaceuticals, Inc|ABOS - Company Aggregate Debts|Debts to Book Capitalization Acumen Pharmaceuticals, Inc|ABOS - Company Long-Term Debts|Company Current Liabilities Acumen Pharmaceuticals
Fundamental valuation:Acumen Pharmaceuticals
Total assets represent the sum of all resources and liabilities of the issuer, calculated reverse-engineered via return on assets (ROA) to identify hidden base distortions. By analyzing changes in the company's financial assets, an investor can assess the capitalization stability of Acumen Pharmaceuticals (ABOS), whose value relies on exclusive patents in Alzheimer's disease therapy and the potential for market dominance.
Key competitors
BIIB (biogen.com) - Company Total Asset Base|Aggregate Company Assets Neurocrine Biosciences, Inc. (NBIX)|Total Business Assets Regencell Bioscience Ltd|Axsome Therapeutics Inc - Company Total Assets|Company Assets ACADIA Corp ACAD|Cumulative Company Assets XENE (Xenon Pharmaceuticals)|vikingtherapeutics.com - Company Total Assets|Aggregate Company Assets Supernus (SUPN)|CPRX: Aggregate Asset Value|Aggregate Company Assets DNLI|Harmony Corp (HRMY) - Company Assets|BHVN (Biohaven Ltd.) - Company Total Assets|Company Total Assets amylyx.com|Company Total Assets TRVI (Trevi Therapeutics, Inc.)|Cumulative Company Assets Praxis Precision Medicines Inc PRAX|Cumulative Company Assets AVXL (Anavex Corp)|CeriBell EEG - Company Total Assets|PRTA: Aggregate Company Assets|ALEC - Cumulative Company Assets|Company Total Assets ANNX|OMER (Omeros) - Company Assets|Aggregate Company Assets Neurogene Corp (NGNE)|Total Business Assets AC Immune Inc (ACIU)|Voyager Therapeutics (VYGR) - Cumulative Company Assets|Aggregate Asset Value NMRA (neumoratx.com)|Scilex (SCLX) - Aggregate Company Assets|Total Asset Value of Company Tevogen Bio Holdings Inc. TVGN|Company Total Assets Alpha Cognition Corp (ACOG)|CGTX - Aggregate Asset Value|IKT: Company Total Assets|SAVA (cassavasciences.com) - Company Total Assets|ASRT - Aggregate Company Assets|Aggregate Asset Value COYA|Aggregate Company Assets VTGN (Vistagen Therapeutics)|Cumulative Company Assets ovidrx.com (OVID)|Company Total Assets CRVO (CervoMed Inc.)|Company Total Assets Alterity Therapeutics Ltd. ATHE|CLNN: Company Total Assets|PEPG - Cumulative Company Assets|Company Total Assets JUNS|Company Assets Relmada Corp|ANVS (Annovis Bio, Inc.) - Cumulative Company Assets|Company Total Assets Grace Tx (GRCE)|Cumulative Company Assets Firefly Neuroscience|Aggregate Business Assets anewmeds.com (KLTO)|Company Total Assets NRSN|Company Total Asset Base Reviva Pharmaceuticals, Inc. RVPH|MTVA: Company Total Assets|NRXS - Cumulative Company Assets|HSDT: Company Total Assets|PASG (Passage Bio) - Company Total Assets|Aggregate Company Assets Neuphoria Therapeutics, Inc.|Aggregate Company Assets NERV|ATHA (Athira Pharma, Inc.) - Aggregate Company Assets|Company Total Asset Base addextherapeutics.com (ADXN)|Company Total Assets ALZN (Alzamend Neuro)|Company Total Assets Cyclerion Therapeutics Inc. CYCN|PTIX - Company Total Assets|KTTA: Aggregate Company Assets|Aggregate Company Assets CRGT|ATXI (avenuetx.com) - Company Assets|BCLI: Aggregate Company Assets|Company Total Asset Base CARA|Aggregate Company Assets Chromocell Therapeutics Corporation CHRO|Total Business Assets eliemtx.com (ELYM)|ITCI: Company Total Assets|LBPH - Company Assets|Marinus Pharmaceuticals, Inc. - Cumulative Company Assets|NKGN: Company Total Assets|Aggregate Company Assets NeuroBo NRBO|SAGE (Sage Therapeutics Inc) - Aggregate Asset Value|Aggregate Company Assets SNPX (Synaptogenix, Inc.)|Company Assets trevena.com|Company Total Assets VIGL|Company Total Assets anewmeds.com (WENA)|Cerevel - Company Total Assets